Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery

被引:81
作者
Jin, Chun Yan [2 ]
Han, Man Hee [2 ]
Lee, Seung S. [2 ]
Choi, Yo Han [1 ]
机构
[1] Elect & Telecommun Res Inst, BioMEMS Team, Taejon 305700, South Korea
[2] Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305701, South Korea
关键词
Microneedle; Transdermal drug delivery; Biocompatible; Deep X-ray lithography; Molding; MICROFABRICATED MICRONEEDLES; DENDRITIC CELLS; FABRICATION; RESPONSES; IMMUNIZATION; SU-8; SKIN;
D O I
10.1007/s10544-009-9337-1
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
The key issues in the development of a microneedle patch as a tool for transdermal drug delivery are safety and delivery performance in addition to economical production. In this paper, novel fabrication methods for an inexpensive microneedle patch made of biocompatible polymer are reported, along with functional verifications for the fabricated microneedle patch through animal models. We combined the merits of in-line microneedles, i.e., easy and economical production, with the superior performance of two-dimensionally arrayed microneedles. One-dimensionally fabricated microneedles were assembled to make two-dimensionally arrayed patches to attain our goal. First, we fabricated strips with one-dimensionally arrayed microneedles through deep X-ray lithography on polymethylmethacrylate or another negative photoresist, SU-8, with sharply reduced exposure time. Second, we assembled microneedle strips to make two-dimensionally arrayed microneedles, which we utilized further for fabrication of molding masters. Finally, we prepared microneedle patches made of polycarbonate by hot embossing with these masters. We then demonstrated the actual delivery of exogenous materials through application on skin via animal experiments, and we found no detectable side effects such as inflammation or allergic reactions at the site of application.
引用
收藏
页码:1195 / 1203
页数:9
相关论文
共 43 条
[1]
Immune regulation in atonic dermatitis [J].
Akdis, CA ;
Akdis, M ;
Trautmann, A ;
Blaser, K .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (06) :641-646
[2]
Becker E. W., 1986, Microelectronic Engineering, V4, P35, DOI 10.1016/0167-9317(86)90004-3
[3]
BRAYBROOK JH, 1997, BIOCOMPATIBLILITY AS
[4]
Dermal and transdermal drug delivery systems: Current and future prospects [J].
Brown, MB ;
Martin, GP ;
Jones, SA ;
Akomeah, FK .
DRUG DELIVERY, 2006, 13 (03) :175-187
[5]
Lipid vesicles and other colloids as drug carriers on the skin [J].
Cevc, G .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :675-711
[6]
Transdermal delivery of desmopressin using a coated microneedle array patch system [J].
Cormier, M ;
Johnson, B ;
Ameri, M ;
Nyam, K ;
Libiran, L ;
Zhang, DD ;
Daddona, P .
JOURNAL OF CONTROLLED RELEASE, 2004, 97 (03) :503-511
[7]
T-cell responses of vaccinated cancer patients [J].
Coulie, PG ;
van der Bruggen, P .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (02) :131-137
[8]
SU-8 as resist material for deep X-ray lithography [J].
Cremers, C ;
Bouamrane, F ;
Singleton, L ;
Schenk, R .
MICROSYSTEM TECHNOLOGIES, 2001, 7 (01) :11-16
[9]
Cross S. E., 2004, Current Drug Delivery, V1, P81, DOI 10.2174/1567201043480045
[10]
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force [J].
Davis, SP ;
Landis, BJ ;
Adams, ZH ;
Allen, MG ;
Prausnitz, MR .
JOURNAL OF BIOMECHANICS, 2004, 37 (08) :1155-1163